Two-Thirds of Workers Say Employer Health Benefits Would Influence GLP-1 Use

New poll finds employer-provided health coverage is a key factor in workers' willingness to take diabetes medication.

Apr. 7, 2026 at 1:43pm

Got story updates? Submit your updates here. ›

A translucent, ghostly X-ray image showing the internal structure of a human pancreas, glowing with an inner light to conceptually represent the biological mechanisms of diabetes.An X-ray view into the body reveals the complex biological factors that influence diabetes treatment decisions.Dallas Today

A new survey from Wondr Health and Harris Poll found that two out of three workers say their employer's health benefits would influence their decision to use GLP-1 medications, which are a class of drugs used to treat type 2 diabetes. The poll results suggest that employer-provided health coverage is a significant factor in workers' willingness to take these medications.

Why it matters

As GLP-1 drugs become more widely prescribed, understanding the role of employer health plans in patients' treatment decisions is crucial. This data highlights how workplace benefits can impact personal healthcare choices, especially for chronic conditions that require ongoing medication.

The details

The survey polled 1,000 U.S. workers and found that 67% said their employer's health plan would influence whether they would use a GLP-1 medication. These drugs have been shown to effectively manage blood sugar levels in people with type 2 diabetes, but can be expensive without insurance coverage. The findings suggest that employers who offer robust health benefits may be able to encourage more of their workers to adhere to recommended diabetes treatments.

  • The survey was conducted in March 2026.

The players

Wondr Health

A digital health company that provides chronic disease management programs for employers and health plans.

Harris Poll

A market research firm that conducts public opinion surveys.

Got photos? Submit your photos here. ›

The takeaway

This data underscores how workplace health plans can significantly influence personal healthcare decisions, especially for chronic conditions that require ongoing treatment. Employers who offer robust diabetes coverage may be able to improve medication adherence and health outcomes for their workers.